Amphastar Pharmaceuticals, Inc. Inventory
Amphastar Pharmaceuticals, Inc. (AMPH) had Inventory of $179.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-06
- 2026-06-30: Inventory, Net $179.91M.
- 2026-03-31: Inventory, Net $170.19M.
- 2025-12-31: Inventory, Net $176.89M.
- 2025-09-30: Inventory, Net $185.93M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $179.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $170.19M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $176.89M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $185.93M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $191.73M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $185.48M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $153.74M 10-K · filed 2026-02-26 |
| 2024-09-30 | $130.32M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $122.41M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $115.49M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $105.83M 10-K · filed 2025-03-03 |
| 2023-09-30 | $109.98M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $104.62M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $103.65M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $103.58M 10-K · filed 2024-02-29 |
| 2022-09-30 | $103.25M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $98.73M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $95.15M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $92.81M 10-K · filed 2023-03-01 |
| 2021-09-30 | $100.24M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $97.93M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $97.11M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $96.83M 10-K · filed 2022-03-11 |
| 2020-09-30 | $108.87M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $104.73M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $107.90M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $110.50M 10-K · filed 2021-03-15 |
| 2019-09-30 | $109.85M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $99.23M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $78.58M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $69.32M 10-K · filed 2020-03-16 |
| 2018-09-30 | $65.41M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $61.68M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $62.78M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $63.61M 10-K · filed 2019-03-15 |
| 2017-09-30 | $69.64M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $74.46M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $78.14M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $79.75M 10-K · filed 2018-03-14 |
| 2016-09-30 | $90.65M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $88.33M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $82.24M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $70.67M 10-K · filed 2017-03-15 |
| 2015-09-30 | $72.42M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $80.17M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $84.89M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $82.33M 10-K · filed 2016-03-15 |
| 2014-09-30 | $88.05M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $106.02M 10-Q · filed 2014-08-13 |
| 2013-12-31 | $69.92M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |